Skip to content

The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02385643
Enrollment
100
Registered
2015-03-11
Start date
2013-09-30
Completion date
2017-07-31
Last updated
2015-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Dependence

Keywords

alcohol dependence, abstinence, relapse prevention, mobile support system

Brief summary

Background: Interactive and mobile technology to manage alcohol use problem potentially provide continuing care by offering emotional and instrumental support anywhere and in time, but the effectiveness for maintaining abstinence has not been examined. the investigators will evaluate in this study whether the smartphone-based support system would improve outcomes for people in recovery for alcohol dependence. To enable continuous self-monitoring and self-management, the phone support system prompts subjects to take Breath Alcohol Concentration (BrAC) tests using a phone application and a Bluetooth sensor unit. The system also offers instantaneous feedback, self-management strategies, and anonymous mutual social support from other subjects. Methods: This three-year project will be conducted in three stages, including pilot study, efficacy evaluation (12 week), and post-intervention follow-up (12 week) stage. Participants will be given a smartphone (if the subject does not have one), breathalyzer and training session. In the pilot study stage,10 subjects will be enrolled to validate the system. In the efficacy evaluation stage, the investigators will conduct a 12-week by enrolling 100 post-detoxification alcohol dependent patients who are randomized to (1) standard treatment (ST) group or (2) standard treatment plus phone-based support group (technology intervention, TI group). Participants will be assessed by Time-Line Follow-Back (TLFB) to record the frequency and quantity of alcohol consumption, visual analogue for craving, Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI), Satisfaction with Life Scale (SWLS), and Quality of life Scale (WHOQOL-BREF) and compared for outcome measures. After the 12-week trial, the investigators will take back the support system and follow the all subjects in both groups for another 12 weeks, i.e. post-intervention stage, to further understand the sustaining benefit from intervention. In addition, the investigators will identify the clinical variables or system factors that are associated with outcome measures. Expected results: In this study, the investigators expect that in treatment-seeking alcohol dependent patients, a smartphone-supported self-management program, adding on to conventional treatment, will be beneficial in improving the drinking outcomes such as a higher abstinence rate, a lower relapse rate, and a lower drinking frequency and quantity.

Interventions

Sponsors

Ming-Chyi Huang
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Age between 20 and 50 years; 2. Use an Android phone as his/her primary phone, or be willing to use an Android phone provided by National Taiwan University as his/her primary phone during the study; 3. Fulfilling the Diagnostic and Statistical Manual version IV (DSM-IV) criteria of alcohol dependence assessed by the Structured Clinical Interview; 4. Complete abstinence for at least 10 days and free of any withdrawal symptoms; and 5. Drug screening test results negative opiates, amphetamines, and ketamine.

Exclusion criteria

1. A current DSM-IV diagnosis of dependence or abuse on other substances except nicotine or the use of one to two low-potency benzodiazepine tablets for sleep impairment; 2. A current mental or psychiatric impairment or disease that required psychotropic medication or inpatient treatment on a psychiatric ward; 3. A history of opioid or psychostimulant abuse; 4. A history of psychosis, including schizophrenia, bipolar I or bipolar II disorder, and major depressive disorder with psychotic features; 5. Current use of any antipsychotics; 6. Homelessness; 7. Pregnancy, nursing, or refusal to use a reliable method of birth control in women; 8. Cognitive deficit and not thus being able to comprehend the informed consent and study procedure

Design outcomes

Primary

MeasureTime frameDescription
Time to first lapse12 weeks
Time to first relapse12 weeks
Cumulative abstinence days12 weeks
Number of drinks per drinking days12 weekseach visit during the 12 weeks: week 1, 2, 4, 8, 12
VAS craving measurement12 weekseach visit during the 12 weeks: week 1, 2, 4, 8, 12
complete abstinence rate12 weeks
Drop-out rate12 weekseach visit during the 12 weeks: week 1, 2, 4, 8, 12

Countries

Taiwan

Contacts

Primary ContactMing-Chyi Huang, MD, PhD
mingchyihuang@gmail.com+886-2-27263141

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026